基本信息
浏览量:5
职业迁徙
个人简介
Chenbo Zeng, a research assistant professor of radiology in the Perelman School of Medicine at the University of Pennsylvania, received an award from The National Comprehensive Cancer Network Oncology Research Program to further study abemaciclib, a drug used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Dr. Zeng’s project will use PET imaging of cell cycle arrest to predict responses to abemaciclib alone or in combination with endocrine therapy. Research funding is being provided by a grant from American pharmaceutical company Eli Lilly and Company.
研究兴趣
论文共 55 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Chenbo Zeng,Chi-Chang Weng, Mark E. Schneider Jr.,Laura Puentes,Aladdin Riad,Kuiying Xu,Mehran Makvandi,Linda Jin,William G. Hawkins,Robert H. Mach
SIGMA PROTEINS: EVOLUTION OF THE CONCEPT OF SIGMA RECEPTORS (2017): 309-330
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn